Alginate-based encapsulation systems for delivery of native IL2 as a successful monotherapy for metastatic cancers is a starting point for encapsulated cell therapies and is essentially only limited by the size of the pores restricting efficient diffusion into the surrounding space. The gene discussed is IL2; the disease is metastatic malignant neoplasm.